Korsana Biosciences, Inc. (KRSA)

30.14 -0.08 (-0.26%) USD  |  NASDAQ  |  Oct 30, 16:00
30.13 -0.01 (-0.03%) After-Hours: 20:00
More

Korsana Biosciences Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for KRSA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2022. Start Trial.
Date Value
October 05, 2026 --
September 28, 2026 --
September 14, 2026 --
February 23, 2026 --
Date Value
February 02, 2026 --
November 11, 2022 --
August 18, 2022 --
August 15, 2022 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
Q32 Bio, Inc. Upgrade
IRulya Therapeutics, Inc. Upgrade
Climb Bio, Inc. Upgrade
PepGen Inc. Upgrade
Bridgebio Oncology Therapeutics, Inc. Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade